<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05071157</url>
  </required_header>
  <id_info>
    <org_study_id>RBHP 2018 PAYSAL</org_study_id>
    <secondary_id>2018-A01907-48</secondary_id>
    <nct_id>NCT05071157</nct_id>
  </id_info>
  <brief_title>Study of the Effects of Adolescent Weight Disorders (Obesity, Anorexia Nervosa) on Heart Function</brief_title>
  <official_title>Study of the Effects of Adolescent Weight Disorders (Obesity, Anorexia Nervosa) on Heart Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to better understand the functioning of the heart of children and adolescents&#xD;
      with anorexia nervosa or obesity, compared to the heart function of control subject. This&#xD;
      project seeks to find out if a weight disorder affects the heart and whether a systematic&#xD;
      cardiac assessment with appropriate management is then to be considered.&#xD;
&#xD;
      To meet this objective, several analyzes are planned including a speckle tracking&#xD;
      echocardiography, allowing a non-invasive study of myocardial deformations.&#xD;
&#xD;
      The hypothesis is that two opposite weight disorders (anorexia nervosa and obesity) lead to&#xD;
      similar complications: inflammation, fibrosis altering the myocardial structure and therefore&#xD;
      its contractility. Both systolic and diastolic dysfunction appear. Investigator hypothesize&#xD;
      that the determinants of this dysfunction involve part of the alteration of body mass, and&#xD;
      partly qualitative alterations specific to each pathology.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective is to evaluate the cardiac dysfunctions through the study of myocardial&#xD;
      deformities in anorexic and obese adolescents, in comparison with controls. The choice of a&#xD;
      pediatric population is explained by the probable precocity of the cardiac repercussions of&#xD;
      these weight disorders. The desire to bring together in the same study two opposite weight&#xD;
      disorders is because a certain number of complications are common to both: repercussions on&#xD;
      the cardiac mass, presence of chronic systemic inflammation, and fibrosis. Comparison to&#xD;
      normo-weighted healthy subjects will make it possible to determine whether certain&#xD;
      alterations are directly attributable to body composition (in the case of a continuum of a&#xD;
      parameter between the three groups) or, on the contrary, independent of body composition.&#xD;
&#xD;
      The search for the mechanisms at the origin of these alterations represents our secondary&#xD;
      objective. For this, a correlation of the cardiac parameters with several factors such as:&#xD;
      duration and severity of disorders, body composition, heart mass, presence of myocardial&#xD;
      fibrosis, epicardial fat level, sympatho-vagal balance (by the cardiac variability), systemic&#xD;
      inflammatory profile and potential pathways signaling involved (metabolomic analysis) will be&#xD;
      carried out. All these parameters may impact cardiac function.&#xD;
&#xD;
      Adolescent girls participating in the study will benefit from a clinical examination with fat&#xD;
      / lean body mass measurement by impedance, assessment of heart rate variability, blood test&#xD;
      (inflammation marker, metabolomic analysis) and ultrasound heart. Thus, screening for heart&#xD;
      disease, and more generally complications of their pathology, will be performed.&#xD;
&#xD;
      This project is important to answer the question of the necessity or not of a systematic&#xD;
      cardiac assessment in these adolescents and the setting up of an adapted care&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 6, 2019</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>systolic global longitudinal strain</measure>
    <time_frame>at inclusion</time_frame>
    <description>echocardiographic parameter of myocardial deformation: index of myocardial systolic function in percent</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>heart rate variability</measure>
    <time_frame>at inclusion during first night</time_frame>
    <description>holter measurement of standard deviation of all intervals between heart beat(SDNN) in ms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>at inclusion</time_frame>
    <description>fat mass and lean mass in percent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiac blood markers</measure>
    <time_frame>at inclusion</time_frame>
    <description>blood sampling: N-Terminal-proBNP in ng/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inflammation blood markers</measure>
    <time_frame>at inclusion</time_frame>
    <description>blood sampling: CRP in mg/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hormonal blood markers</measure>
    <time_frame>at inclusion</time_frame>
    <description>blood sampling: oestradiol in pg/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood hemoglobin</measure>
    <time_frame>at inclusion</time_frame>
    <description>blood sampling: in g/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ionogram blood markers</measure>
    <time_frame>at inclusion</time_frame>
    <description>blood sampling: blood potassium in mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rhythm and conduction</measure>
    <time_frame>at inclusion</time_frame>
    <description>electrocardiogram to determine ECG QT Interval</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Anorexia Nervosa</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>anorexia nervosa</arm_group_label>
    <description>girls between 12 and 18 years old with behavioral eating disorder characterized by a drastic reduction in intakes resulting in weight loss and a BMI ≤ 17.5 kg / m2. Anorexia can be restrictive pure or associated with bulimia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>obesity</arm_group_label>
    <description>girls between 12 and 18 years old with a BMI projecting ≥ 30 kg / m2 at the age of 18 (IOTF C30).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal weight</arm_group_label>
    <description>girls between 12 and 18 years old without BMI abnormality, without eating disorders, without serious medical pathology</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>echocardiography</intervention_name>
    <description>speckle tracking echocardiography&#xD;
evaluation of cardiac variability by recording heart rate as several hours (POLAR watch)&#xD;
bioimpedance&#xD;
blood test for biological assays (metabolomic analysis)</description>
    <arm_group_label>anorexia nervosa</arm_group_label>
    <arm_group_label>normal weight</arm_group_label>
    <arm_group_label>obesity</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood sample for inflammatory factors (CRP, sedimentary rate, metabolomic)&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        girls between 12 and 18 with or without weight disorders&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  girls between 12 and 18, affiliated to a social security&#xD;
&#xD;
          -  with behavioral eating disorder characterized by a drastic reduction in intakes&#xD;
             resulting in weight loss and a BMI ≤ 17.5 kg / m2. Anorexia can be restrictive pure or&#xD;
             associated with bulimia&#xD;
&#xD;
          -  or, with a BMI projecting ≥ 30 kg / m2 at the age of 18 (IOTF C30)&#xD;
&#xD;
          -  or, without BMI abnormality, without eating disorders, without serious medical&#xD;
             pathology&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  for anorexics, uncorrected nutritional deficiency&#xD;
&#xD;
          -  for the obese, secondary obesity&#xD;
&#xD;
          -  for all, inability to provide informed consent, pregnancy or breastfeeding, heart&#xD;
             disease, high blood pressure, sleep apnea syndrome, dyslipidemia, diabetes, chronic&#xD;
             pathology including inflammatory.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justine Paysal</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lise Laclautre</last_name>
    <phone>334.73.754.963</phone>
    <email>promo_interne_drci@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU clermont-ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lise Laclautre</last_name>
    </contact>
    <investigator>
      <last_name>Justine Paysal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 14, 2021</study_first_submitted>
  <study_first_submitted_qc>September 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2021</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cardiac function</keyword>
  <keyword>adolescent</keyword>
  <keyword>obesity</keyword>
  <keyword>speckle tracking echocardiography</keyword>
  <keyword>anorexia nervosa</keyword>
  <keyword>metabolomic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

